Please login to the form below

Not currently logged in
Email:
Password:

AZ’s Imfinzi gets US OK in small cell lung cancer, challenging Tecentriq

AstraZeneca AZ

First checkpoint inhibitor to challenge Roche's Tecentriq in this indication

Amarin shares tumble following Vascepa patent loss

VascepaJudgement invalidates six key patents on fish-oil derived med

Bayer gets EU nod for prostate cancer drug Nubeqa

Bayer symbolEnters an increasingly competitive market

FDA grants emergency authorisation to chloroquine for COVID-19

FDA headquarters White OakNovartis and Bayer donate anti-malaria drugs to US stockpile

In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa

SanofiMonthly meeting held remotely for the first time due to COVID-19 pandemic

Merck gets first approval for MET inhibitor tepotinib in Japan

Merck KGaAFirst worldwide approval for MET inhibitor

UPDATED: Gilead drops remdesivir’s orphan drug designation

GileadDecision comes amid intense public criticism of the regulatory status

FDA says no to Lilly, Boehringer’s Jardiance in type 1 diabetes

boehringer-jardiance-diabetesFormally rejects extended use of SGLT2 inhibitor

FDA green lights rapid coronavirus diagnostic test

FDA webTest can diagnose positive cases in approximately 45 minutes

Brexit‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

Latest regulatory appointments

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics